When trying to remove life-threatening clots from blood vessels, current technologies are successful on only about half of ...

SNS Insider Unveils Strategic Insights into the U.S. Ventricular Assist Device Market’s Growth—Valued at USD 0.73 Billion in 2023—While North America Dominated the Global Market with 58.1% Share in ...

After surviving breast cancer twice, Judy Riede was living an active life in Wyoming when sudden heart failure changed ...

What has put a rocket under this stock on Friday? Let's find out. The post Why this ASX All Ords stock is jumping 9% today ...

Background: Resting left ventricular outflow tract obstruction (LVOTO) occurs in 25% of patients with hypertrophic cardiomyopathy (HCM) and is an important cause of symptoms and disease progression.

Irregular heartbeats affect more than 4 million Americans, and for many, the treatment is cardiac ablation—a procedure that ...

The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a ...

Implantable cardioverter-defibrillators (ICDs), the first line of therapy for preventing sudden cardiac death in high-risk patients, deliver appropriate shocks for termination of ventricular ...

The generalisability of these relationships between cohorts is unknown. The aims of this study were to compare left ventricular (LV) shapes in patients with differing cardiovascular risk factor ...

Whether T-cell recruitment to the left ventricle (LV) participates in the development of ... Research Interchange (NDRI), and from end-stage HF subjects after LV-assisted device support (n=3). The ...